Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial - Kang, Y K; Ryu, M H; Yoo, C (Lancet Oncol, 2013)
, et al.